These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18830869)

  • 1. Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report.
    Lee GS
    J Cosmet Laser Ther; 2008 Dec; 10(4):234-6. PubMed ID: 18830869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen.
    Taylor MB; Yanaki JS; Draper DO; Shurtz JC; Coglianese M
    J Drugs Dermatol; 2013 Jan; 12(1):45-50. PubMed ID: 23377327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lasers].
    Passeron T
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S108-14. PubMed ID: 23260518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.
    Polnikorn N
    J Cosmet Laser Ther; 2008 Sep; 10(3):167-73. PubMed ID: 18788035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy.
    Ryu HJ; Kim J
    J Cosmet Laser Ther; 2013 Oct; 15(5):290-2. PubMed ID: 23464754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory arcuate hyperpigmentation using a fractional photothermolysis system.
    Cho SB; Lee SJ; Kang JM; Kim YK; Oh SH
    J Dermatolog Treat; 2010 Mar; 21(2):107-8. PubMed ID: 19431062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma.
    Zhou X; Gold MH; Lu Z; Li Y
    Dermatol Surg; 2011 Jul; 37(7):962-70. PubMed ID: 21615824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
    Brown AS; Hussain M; Goldberg DJ
    J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma.
    Sobhi RM; Sobhi AM
    J Cosmet Dermatol; 2012 Mar; 11(1):65-71. PubMed ID: 22360337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is there any place for laser devices in the treatment of melasma?].
    Badri T; Hammami H; Benmously R; Mokhtar I; Fenniche S
    Ann Dermatol Venereol; 2011; 138(4):319-20. PubMed ID: 21497261
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: a prospective study.
    Polnikorn N
    J Cosmet Laser Ther; 2010 Jun; 12(3):126-31. PubMed ID: 20482238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma.
    Huh CH; Seo KI; Park JY; Lim JG; Eun HC; Park KC
    Dermatology; 2003; 206(4):316-20. PubMed ID: 12771472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
    Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
    J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hyperpigmentation-melasma with photodynamic therapy.
    Marcus L
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):9-11. PubMed ID: 16485875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO2 laser device.
    Tan KL; Kurniawati C; Gold MH
    J Drugs Dermatol; 2008 Aug; 7(8):774-7. PubMed ID: 18720695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy.
    Cho SB; Kim JS; Kim MJ
    Clin Exp Dermatol; 2009 Dec; 34(8):e847-50. PubMed ID: 19817757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of low-energy QS Nd:YAG and QS alexandrite laser for melasma].
    Wang HW; Liu KY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):45-7. PubMed ID: 19317058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotted leucoderma after treatment of facial hyperpigmentation on hemodialysis patients employing 1064-nm Q-switched Nd:YAG laser.
    Hwang CY; Lin CS; Tseng ML; Liu HN
    J Cosmet Laser Ther; 2010 Feb; 12(1):47-50. PubMed ID: 19929290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study.
    Wind BS; Kroon MW; Meesters AA; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Bos JD; Wolkerstorfer A
    Lasers Surg Med; 2010 Sep; 42(7):607-12. PubMed ID: 20806385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.
    Jang WS; Lee CK; Kim BJ; Kim MN
    Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.